NR 507 / NR507 MIDTERM EXAM
Advanced Pathophysiology — Expanded Original Q&A; Review
Premium-style study edition
Original exam-preparation questions, mechanism-based explanations, clinical reasoning, and high-yield review.
Important source note
The referenced Stuvia listing is a 32-page Q&A; exam-elaboration document. Its public preview includes questions on
sickle-cell disease, thalassemia, hemoglobin genetics, coronary artery disease, pulmonary circulation, and CAD risk
factors. This guide uses those publicly visible topics only as topical orientation and does not reproduce the paid
document or its locked questions.
Study strategy: For every question, identify the disease → mechanism → physiologic consequence → clinical
manifestation. When an answer choice merely names a symptom while another explains the mechanism, the
mechanistic choice is usually the stronger pathophysiology answer.
NR507 Advanced Pathophysiology • Original expanded study resource Page 1
, CONTENTS
1. 1. Sickle Cell Disease & Hemoglobinopathies
2. 2. Thalassemia & RBC Disorders
3. 3. Hematopoiesis, Anemia & RBC Indices
4. 4. Cardiovascular Pathophysiology & CAD
5. 5. Cardiac Blood Flow, Ischemia & Infarction
6. 6. Inflammation, Cellular Injury & Repair
7. 7. Immunity & Hypersensitivity
8. 8. Pulmonary Pathophysiology
9. 9. Renal Pathophysiology
10. 10. Endocrine & Metabolic Disorders
11. 11. Integrated Clinical Cases
12. 12. Final Exam Drill & High-Yield Traps
NR507 Advanced Pathophysiology • Original expanded study resource Page 2
, 1. Sickle Cell Disease & Hemoglobinopathies
QUESTION 1
What is the core molecular defect in sickle cell disease?
Answer: A pathogenic variant in the beta-globin gene produces hemoglobin S. A single amino-acid substitution changes
hemoglobin behavior, particularly when deoxygenated, allowing HbS molecules to polymerize and distort RBCs.
Exam clarification: The key concept is a structural hemoglobin abnormality, not a simple reduction in RBC production.
Clinical connection: Polymerization promotes rigidity, hemolysis, and microvascular obstruction.
QUESTION 2
Why does deoxygenation promote sickling?
Answer: Deoxygenated HbS is less soluble and can polymerize into long intracellular structures. The RBC becomes
rigid and assumes a sickle shape, especially when dehydration, acidosis, or hypoxemia favors polymerization.
Exam clarification: Sickling is dynamic; cells can initially recover their shape if the polymerization process reverses.
Clinical connection: Repeated sickling damages the RBC membrane and shortens RBC survival.
QUESTION 3
Why is sickle cell disease associated with vaso-occlusive pain?
Answer: Rigid sickled RBCs obstruct small vessels and interact abnormally with endothelium and leukocytes. Local
ischemia produces tissue injury, inflammation, and severe pain.
Exam clarification: Pain is downstream of microvascular obstruction and ischemia.
Clinical connection: Hydration status, hypoxemia, acidosis, infection, and other stressors can worsen sickling.
QUESTION 4
Why is stroke a major complication of sickle cell disease?
Answer: Chronic hemolysis, endothelial dysfunction, vascular injury, and abnormal cerebral blood flow can contribute to
cerebrovascular disease. Large-vessel vasculopathy and other vascular abnormalities increase ischemic stroke risk.
Exam clarification: Do not assume every neurologic event is hemorrhagic; ischemic cerebrovascular injury is an important
complication.
Clinical connection: Neurologic deficits in a patient with sickle cell disease require urgent evaluation.
QUESTION 5
What causes chronic anemia in sickle cell disease?
Answer: Sickled RBCs are prematurely destroyed, producing chronic hemolytic anemia. Bone marrow increases
erythropoiesis to compensate, but RBC survival remains substantially shortened.
Exam clarification: This is a hemolytic anemia rather than primarily a failure of marrow production.
Clinical connection: Reticulocytosis may reflect the marrow response if the marrow is functioning.
QUESTION 6
How does functional asplenia develop in sickle cell disease?
Answer: Repeated splenic vaso-occlusion and infarction progressively damage splenic tissue, eventually causing
functional asplenia.
Exam clarification: Loss of splenic function increases susceptibility to certain encapsulated organisms.
Clinical connection: A patient can have an enlarged spleen early in disease and later develop a small, fibrotic, poorly
functioning spleen.
QUESTION 7
What is autosomal recessive inheritance?
NR507 Advanced Pathophysiology • Original expanded study resource Page 3
Advanced Pathophysiology — Expanded Original Q&A; Review
Premium-style study edition
Original exam-preparation questions, mechanism-based explanations, clinical reasoning, and high-yield review.
Important source note
The referenced Stuvia listing is a 32-page Q&A; exam-elaboration document. Its public preview includes questions on
sickle-cell disease, thalassemia, hemoglobin genetics, coronary artery disease, pulmonary circulation, and CAD risk
factors. This guide uses those publicly visible topics only as topical orientation and does not reproduce the paid
document or its locked questions.
Study strategy: For every question, identify the disease → mechanism → physiologic consequence → clinical
manifestation. When an answer choice merely names a symptom while another explains the mechanism, the
mechanistic choice is usually the stronger pathophysiology answer.
NR507 Advanced Pathophysiology • Original expanded study resource Page 1
, CONTENTS
1. 1. Sickle Cell Disease & Hemoglobinopathies
2. 2. Thalassemia & RBC Disorders
3. 3. Hematopoiesis, Anemia & RBC Indices
4. 4. Cardiovascular Pathophysiology & CAD
5. 5. Cardiac Blood Flow, Ischemia & Infarction
6. 6. Inflammation, Cellular Injury & Repair
7. 7. Immunity & Hypersensitivity
8. 8. Pulmonary Pathophysiology
9. 9. Renal Pathophysiology
10. 10. Endocrine & Metabolic Disorders
11. 11. Integrated Clinical Cases
12. 12. Final Exam Drill & High-Yield Traps
NR507 Advanced Pathophysiology • Original expanded study resource Page 2
, 1. Sickle Cell Disease & Hemoglobinopathies
QUESTION 1
What is the core molecular defect in sickle cell disease?
Answer: A pathogenic variant in the beta-globin gene produces hemoglobin S. A single amino-acid substitution changes
hemoglobin behavior, particularly when deoxygenated, allowing HbS molecules to polymerize and distort RBCs.
Exam clarification: The key concept is a structural hemoglobin abnormality, not a simple reduction in RBC production.
Clinical connection: Polymerization promotes rigidity, hemolysis, and microvascular obstruction.
QUESTION 2
Why does deoxygenation promote sickling?
Answer: Deoxygenated HbS is less soluble and can polymerize into long intracellular structures. The RBC becomes
rigid and assumes a sickle shape, especially when dehydration, acidosis, or hypoxemia favors polymerization.
Exam clarification: Sickling is dynamic; cells can initially recover their shape if the polymerization process reverses.
Clinical connection: Repeated sickling damages the RBC membrane and shortens RBC survival.
QUESTION 3
Why is sickle cell disease associated with vaso-occlusive pain?
Answer: Rigid sickled RBCs obstruct small vessels and interact abnormally with endothelium and leukocytes. Local
ischemia produces tissue injury, inflammation, and severe pain.
Exam clarification: Pain is downstream of microvascular obstruction and ischemia.
Clinical connection: Hydration status, hypoxemia, acidosis, infection, and other stressors can worsen sickling.
QUESTION 4
Why is stroke a major complication of sickle cell disease?
Answer: Chronic hemolysis, endothelial dysfunction, vascular injury, and abnormal cerebral blood flow can contribute to
cerebrovascular disease. Large-vessel vasculopathy and other vascular abnormalities increase ischemic stroke risk.
Exam clarification: Do not assume every neurologic event is hemorrhagic; ischemic cerebrovascular injury is an important
complication.
Clinical connection: Neurologic deficits in a patient with sickle cell disease require urgent evaluation.
QUESTION 5
What causes chronic anemia in sickle cell disease?
Answer: Sickled RBCs are prematurely destroyed, producing chronic hemolytic anemia. Bone marrow increases
erythropoiesis to compensate, but RBC survival remains substantially shortened.
Exam clarification: This is a hemolytic anemia rather than primarily a failure of marrow production.
Clinical connection: Reticulocytosis may reflect the marrow response if the marrow is functioning.
QUESTION 6
How does functional asplenia develop in sickle cell disease?
Answer: Repeated splenic vaso-occlusion and infarction progressively damage splenic tissue, eventually causing
functional asplenia.
Exam clarification: Loss of splenic function increases susceptibility to certain encapsulated organisms.
Clinical connection: A patient can have an enlarged spleen early in disease and later develop a small, fibrotic, poorly
functioning spleen.
QUESTION 7
What is autosomal recessive inheritance?
NR507 Advanced Pathophysiology • Original expanded study resource Page 3
